Minnesota medtech companies devise treatments for opioid-use disorder

The creators of the InfiSIS, a multimodal neuromodulator device developed by Osseo-based startup SmartImplantSystems specifically as an alternative to opioids, expects the neuropathic device to be effective in addressing the multiple forms of pain that can collectively plague post-operative and other patients, particularly in the back and the legs. | Photo courtesy of Omid Souresrafil/SmartImplantSystems